1. Introduction
===============

A number of studies in developing countries have demonstrated that HIV transmission between serodiscordant couples/partners is a major contributor to new HIV infections, especially in the countries of Sub-Saharan Africa.^\[[@R1]--[@R3]\]^ This is concerning as nearly half of HIV-positive individuals in East and Southern Africa have reported being in HIV serodiscordant relationships.^\[[@R4]\]^ For instance, among married couples/partners in the general population in rural Uganda, 5% to 7% were estimated to be HIV serodiscordant.^\[[@R2],[@R5]\]^ HIV transmission rates within serodiscordant couples/partners are typically high, ranging from 3.7 to 19.0 per 100 person years (PYs) at risk.^\[[@R2],[@R6]--[@R11]\]^ In China, a meta-analysis reported the overall HIV seroconversion rate among serodiscordant couples in China to be 1.2 per 100 PYs.^\[[@R12]\]^ Previous research in Guangxi Province has demonstrated that the HIV seroconversion rate among serodiscordant couples was 2.5 per 100 PYs,^\[[@R13]\]^ about 2 times higher than the result of the meta-analysis in China, but much lower than the results of the African countries listed above.

Guangxi is a province in Southern China that bears a high disease burden caused by HIV/AIDS. It is a mountainous province with a large population of ethnic minorities and is bordered by Guangdong province to the east, Yunnan province to the west, Vietnam, and the Gulf of Tonkin to the South. As one of the less developed and more rural provinces in China with the major industry being farming, medical infrastructure and access to care continue to be challenges and result in health disparities between this province and other areas of China. Currently \>110,000 people in Guangxi are registered to be living with HIV and \>63,000 patients have been treated. As of December 31, 2016, Guangxi was ranked third among all the provinces of China with a general population HIV prevalence rate of 1.30 per 1000. Additionally, compared with the 35.5% of patients presenting late with HIV/AIDS in China, the percentage presenting late in Guangxi has been \>51% of total registrations,^\[[@R14]\]^ ranking the province second among the 31 provinces in China. This has been a high public health priority issue in Guangxi, as those with HIV/AIDS who present to care later have worse health outcomes and a higher possibility to spread HIV to others, including their spouses/partners.^\[[@R15]\]^

Guangxi is also unique in China because the route of transmission is most likely to be reported as heterosexual sexual behavior.^\[[@R16]\]^ Among those who registered in 2016, \>92% reported that they were infected by heterosexual sexual transmission, making Guangxi the highest for this reported route of transmission in China. Therefore, the aim of this study was to calculate the incident rate of HIV among serodiscordant couples/partners using data from a cohort of HIV/AIDS patients in Guangxi, and to estimate the population risk of HIV seroconversion among serodiscordant spouses/partners in China. Our findings will provide the HIV incidence rate among serodiscordant spouses/partners and add to the literature of HIV seroconversion in areas where HIV transmission from heterosexual contact is \>90%.

2. Methods
==========

2.1. Participants
-----------------

Participants in this study were registered in an observational cohort in 2010. We collected their spouse/partner information purposely 6 and 12 months from the baseline. To be eligible for the study, participants must have: been 15 years old and above; had a spouse/partner newly registered as HIV positive; not have a positive test for HIV at baseline themselves; and been married, divorced, currently single but married before, or a separated spouse to the newly registered HIV positive spouse/partner. Clinical review for both the patient and their spouse/partner was required every 6 months and blood was sampled to test for HIV antibody and CD4 count simultaneously.

Participants were excluded if: they reported being from Hong Kong, Macaw, other nations, or did not report a permanent address; their spouse/partner tested HIV positive at baseline; their spouse/partner was reported to be dead at baseline; and they reported being single at baseline.

2.2. Data collection
--------------------

Data were extracted from a HIV serodiscordant couples observation cohort of those who registered from January 1st to December 31, 2010. Standard follow-up information was recorded by program staff and included identification number, spouse/partner HIV testing status, use of antiretroviral therapy (ART), time of follow-up, CD4 cell count, and World Health Organization (WHO) clinical disease stage. Household information such as demographic characteristics, socioeconomic, and health status were collected at the baseline and follow-ups, and blood samples for HIV testing were collected at all 3 time points. Laboratory testing of blood samples followed the national HIV laboratory testing operational guidelines. A 6-month follow-up period was used during the course of a year. Spouse/partner information and HIV testing were collected during both of these follow-up activities. If a participant was lost to follow-up (3 months' absence from a clinic since last visit), a site visit of the participant\'s address was conducted by clinic staff to confirm their absence or death, with information collected at the site visit including the date of the last visit to the clinic or date of death. For participants who were missing or reported to have died in the observational period, the date of absence or death was considered the endpoint of the observation.

Written consent for the study was signed by the participants before the initial HIV confirmation testing; spouse/partner' HIV testing and follow-up were included as part of the consent process. To protect participant confidentiality, all data were de-identified by removing names, identification numbers, addresses, and other private information. All analyses were performed using this de-identified dataset.

2.3. Response variable imputation
---------------------------------

In this analysis, the dependent variable was "spouse/partner HIV testing status". In certain cases, testing status was missing even though the contact history notes indicated that the participant had a HIV positive spouse/partner, or the participant\'s "sample source" was from the positive spouse/partner testing. Imputation method has presented a rise trend in medical research recently.^\[[@R17]\]^ Under this circumstance, testing status was imputed as "positive" following the criteria: the "contact history," "notes," or "sample source" noted that the spouse/partner HIV testing result to be positive; the spouse had a HIV-positive card registered "no" in the dataset; previous spouse/partner was HIV-positive (she/he died or was separated) and current spouse/partner was HIV-negative; or spouse/partner was HIV-negative but partner was positive, or spouse/partner was positive but partner was negative.

2.4. Statistical analysis
-------------------------

We used R software (version 3.2.2, R Foundation for statistical Computing, Vienna, Austria) for analysis. Data were stratified and analyzed by sex, age group, ART use, education, and marital status. PYs of follow-up, prevalence of HIV seroconversion based on testing results, and seroconversion density were calculated. Transmission odds ratios (ORs) values were estimated with the Mantel-Haenszel Estimation method, with results compared using *χ*^2^ tests. Finally, HIV transmission risk was estimated for each stratification variable to understand the degree of the HIV transmission risk.

2.5. Calculation of PY of follow-up
-----------------------------------

We calculated the PYs from baseline to 6 months and from 7 to 12 months separately, and then summed these values for total PYs in the first-year follow-up. The end-point of the study was set to the end of the 12th month with the exception of when a participant was lost to death or was missing. For participants who were missing from baseline to 6 months, but reported for testing in the 7- to 12-month period, the days considered PYs from baseline to 6 months were imputed to be zero, and follow-up days from 7 to 12 months were considered to be from the first day of 7 months to the end of the year.

3. Results
==========

As can be seen in Table [1](#T1){ref-type="table"}, 5544 participants were recruited in the present study, 2731.85 PYs were provided for the cohort in the first-year follow-up period (median \[M\]: 0.55 PYs, interquartile range \[IQR\]: 0.29, 0.80). Among them, 659.84 PYs of follow-up were provided for those with HIV/AIDS who had a HIV-tested spouse (M: 0.61 PYs, IQR: 0.35, 0.82); 2072.02 PYs of follow-up were provided for those with HIV/AIDS who had a HIV testing-naïve spouse/partner (M: 0.53 PYs, IQR: 0.28, 0.79). Across age groups, although more HIV/AIDS cases were concentrated from the first quartile to third quartile of PYs at follow-up, the median of PYs of follow-up declined steadily (Fig. [1](#F1){ref-type="fig"}). Among this cohort, 4095 (73.86%) were males; the 25- to 34- and 35- to 44-year age groups were the majority, 61.81% reported that they were farmers; 87.77% indicated that their educational attainment was junior high school or below (with junior high school being 44.12%, with elementary school being 39.30%, and illiteracy being 4.35%).

###### 

Baseline characteristics of HIV patients with serodiscordant spouses/partners.
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Among spouse/partners at baseline, 48.9% reported that they had ever been tested for HIV and 51.1% tested naïve. Among spouse/partner who had ever tested, the percentage of HIV seroconversion was 23.4% in 6 months and 21.2% at 12 months; with incidence being 63.71/100 PYs (430/674.94) in 6 months and 33.2/100 PYs (567/1707.12 PYs) in 12 months.

As can be seen in Table [2](#T2){ref-type="table"}, ORs were calculated to understand risk factors for HIV seroconversion. Compared with males in this cohort, the risk of HIV acquisition was higher among female partners, the OR value was 2.09 (95% confidence interval \[CI\]: 1.67, 2.63) times higher for females at the 6-month follow-up (*P* *\<* 0.0001). Higher risk for HIV acquisition was observed in the 55- to 64-year age group population with an OR value 2.23 (95% CI: 1.87, 2.66), married HIV individual with 2.45 (95% CI: 1.30, 4.63), and illiterate HIV/AIDS with 6.66 (95% CI: 2.31, 19.24). Compared with those who were taking ART, the OR value in ART-naïve group was 1.14 (95% CI: 0.91, 1.43), there was no significant difference between ART and ART-naïve group. Except for education, the observational results at the 12-month follow-up were consistent with the results of 6-month follow-up including increased risk among females, the 55- to 64-year age group, and for those who were married (Table [2](#T2){ref-type="table"}, Figs. [2](#F2){ref-type="fig"}--[4](#F4){ref-type="fig"}).
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Seroconversion in HIV serodiscordant couples and odds ratio for testing within 1 year\'s follow-up.
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4. Discussion
=============

The aim of this study was to estimate the incident rate of HIV among serodiscordant couples/partners using data from a cohort of HIV/AIDS patients in Guangxi. Results from this study indicate that Guangxi has a high rate of HIV seroconversion among serodiscordant spouses/partners after 1 year of follow-up. Additionally, the risk of transmission from female to male spouse/partners was approximately 2 times higher than from male to females, results which are consistent with the findings in the HPTN052 trial.^\[[@R24]\]^ Those in the 55- to 64-year age group, who were married, and who had less education had the highest HIV transmission risk during the first 6 months of the study, and these findings were consistent across the year. Unfortunately, the potentially positive impact of ART to reduce HIV transmission between serodiscordant spouse/partner was not observed in this study. It is likely that this finding is a result of low coverage or use of ART in this sample. Similar results have been observed in rural South Africa among HIV-infected people.^\[[@R25]\]^

Our results provide insight into seroconversion among HIV serodiscordant spouses/partners. This study indicates a much higher seroconversion rate than the results of a previous Meta-analysis in China ^\[[@R12]\]^ and previous studies.^\[[@R13],[@R18]\]^ We consider the differences possibly to be related to features of the present study. First, this study used imputation to address missing and inconsistent data and this may have influenced the results. However, a standard imputation method was used to impute spouse/partner HIV testing status to adjust for possible reporting bias.^\[[@R19],[@R20]\]^ Second, as compared with other studies, this study included different participant recruitment criteria. The participants of our cohort included any spouse/partner who had not died or did not have a HIV positive test result at baseline. Other studies typically recruit participants whose spouses/partners have negative HIV tests at baseline, ruling out the HIV test naïve individuals which might have a high possibility of HIV seroconversion within the observational period. Third, other studies indicate that those with HIV/AIDS who present for treatment later have a higher possibility of transmitting HIV.^\[[@R15]\]^ Guangxi is ranked second among the 31 provinces in China.^\[[@R14]\]^ Although it did not assess late presentation, the current high seroconversion rate may be a result of the local context of access and use of HIV testing services.

This study also indicated that the risk of HIV transmission of females was 2 times higher than of males. Similar results have been observed in rural Uganda and in the HPTN 052 trial.^\[[@R1]\]^ The following reasons may explain the result. First, Guangxi is rural area with high levels of poverty in Southern China and females from villages often migrate to larger cities; it is not uncommon for these women to participate in commercial sex. HIV prevalence in female sex workers is high and transmission between sex workers and their clients is a major public health concern.^\[[@R21],[@R28]\]^ Second, HIV prevalence in female sex workers in Guangxi was high.^\[[@R28]\]^ When they return home, we observed transmission from female to male. Based on results of this study, we know that males in this study tended to be older when diagnosed with HIV, with the median age being 51.4 years among males and 38.1 years among females. This may likely reflect the fact that HIV/AIDS is typically diagnosed late in Guangxi. In this cohort, the largest age group for seroconversion among females was 25 to 34 years, whereas in male was 55 to 64 years. This difference may be attributed to differences in use of medical care, with women in childbearing years visiting clinics more frequently at younger ages. Additionally, the high rate of HIV infection among older participants in this study is of great concern because of the possibility for more rapid disease progression, high mobility, and high mortality in this population.^\[[@R22]\]^ For example, the 55- to 64-year male age group suffered the highest disease burden in this cohort. The reasons may be related to accessing diagnosis and care at a later stage among males than females.^\[[@R26]\]^ Additionally, high seroconversion found in this study among older males may be related to cultural practices of commercial sex activities.^\[[@R27]\]^ The findings in our cohort emphasize that provincial HIV prevention programs should provide more active HIV testing and counseling to the spouses/partners to identify HIV status as early as possible to prevent further transmission.

Research has shown that initiation of ART can reduce HIV transmission, including transmission in serodiscordant couples.^\[[@R8],[@R23]\]^ For instance, the HPTN 052 trial showed that ART could reduce 96% transmission between couples under a strict use conditions.^\[[@R24]\]^ Although ART coverage is now much greater in Guangxi, in the pre-ART period in which data collection for this study was undertaken, coverage in this cohort was 32%, similar to coverage seen in a study of Kenyan serodiscordant couples.^\[[@R29]\]^ Taking this into account, results of this study indicated that ART did not reduce HIV transmission in serodiscordant couples. Other research in this province indicates that barriers to ART use included lower socioeconomic status, ART drugs being out of stock, an insufficient number of HIV treatment facilities, fear of ART side effects, stigma and disclosure, and partner stress to be linked to lower medication adherence.^\[[@R30]\]^ The current findings related to ART in this study may be attributed to low ART coverage and insufficient adherence to achieve sustained virological suppression in population. It should also be considered that ART initiation may not have been sufficient to prevent HIV transmission. Participants may have acquired HIV acquisition in this study while their HIV-positive spouse/partner was beginning the ART regimen, considering the 51% of patients in Guangxi that present late as HIV-positive.^\[[@R14]\]^ Similarly, a study in Uganda also found that low-population ART coverage was not successful in preventing HIV transmission from HIV-positive individuals to serodiscordant partners.^\[[@R31]\]^ These results indicate that a public health priority in Guangxi should be an expanded HIV testing system and a rapid scale-up of ART coverage among those newly diagnosed with HIV to lower HIV transmission among discordant partners.

This study also has limitations. First, it is probable that HIV acquisition may have been misclassified as transmission between partners, but related to other risk factors such as sex with other men and/or women. Second, some spouses/partners' HIV infection may be obtained before the registration, but were confirmed in the first year of follow-up and this study may be an overestimate of the seroconversion incident rate of HIV in this period. Third, a number of HIV transmissions between discordant couple/partner may have occurred before ART initiation of the first HIV-positive spouse/partner. This might underestimate the protective role of ART in the HIV transmission between discordant couple/partner.

In summary, we have measured HIV incidence among serodiscordant couples/partners in this study, and calculated the risk of HIV transmission among serodiscordant couples/partners according to different population characteristics stratifications. Our study has provided greater insight into HIV serodiscordant transmission rates during 1-year follow-up in Guangxi, Southern China. This study also identified risk factors for HIV transmission, and provided quantitative transmission risk across behavioral risk factors and demographic characteristics. A significantly higher transmission rate was observed in female HIV-positive individuals (OR = 2.3), aged 55 to 64 (OR = 2.2), married status (OR = 2.5), whereas ART as a protective factor against transmission was not observed (OR = 0.5).
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